KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 127 filers reported holding KYMERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $432,454 | +3.5% | 31,112 | +71.3% | 0.00% | 0.0% |
| Q2 2023 | $417,658 | -49.5% | 18,167 | -35.0% | 0.00% | -50.0% |
| Q1 2023 | $827,861 | +14.7% | 27,940 | -3.4% | 0.00% | +100.0% |
| Q4 2022 | $721,817 | +44.9% | 28,919 | +25.9% | 0.00% | 0.0% |
| Q3 2022 | $498,000 | +25.1% | 22,975 | +13.0% | 0.00% | 0.0% |
| Q2 2022 | $398,000 | +83.4% | 20,325 | +449.5% | 0.00% | – |
| Q3 2021 | $217,000 | -77.2% | 3,699 | -85.0% | 0.00% | -100.0% |
| Q1 2021 | $951,000 | +166.4% | 24,684 | +395.8% | 0.00% | +100.0% |
| Q4 2020 | $357,000 | – | 4,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |